Gomesin acts in the immune system and promotes myeloid differentiation and monocyte/macrophage activation in mouse
dc.citation.volume | 85 | |
dc.contributor.author | Buri, Marcus Vinicius [UNIFESP] | |
dc.contributor.author | Dias, Carolina Carvalho [UNIFESP] | |
dc.contributor.author | Barbosa, Christiano Marcello Vaz [UNIFESP] | |
dc.contributor.author | Nogueira-Pedro, Amanda [UNIFESP] | |
dc.contributor.author | Ribeiro-Filho, Antonio C. | |
dc.contributor.author | Miranda, Antonio [UNIFESP] | |
dc.contributor.author | Paredes-Gamero, Edgar Julian [UNIFESP] | |
dc.coverage | New York | |
dc.date.accessioned | 2020-07-31T12:47:29Z | |
dc.date.available | 2020-07-31T12:47:29Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Due to the cytotoxic effect of antimicrobial peptides (AMP) against several microorganism and tumor cells has been proposed their association with the immune system. However, just a few reports have shown this relationship. In this study, mice were treated with gomesin, a beta-hairpin AMP that exhibit high cytotoxicity against bacterial and tumor cells. Different effects in the immune system were observed, such as, decrease of CD3(+) in T lymphocytes (Control: 17.7 +/- 1.4% | en |
dc.description.abstract | Gomesin: 7.67 +/- 11.2%) and in hematopoietic progenitors and increase of hematopoietic stem cell (Control: 0.046 +/- 0.004% | en |
dc.description.abstract | Gomesin: 0.067 +/- 10.003%), B220(+) B lymphocytes (Control: 38.63 +/- 1.5% | en |
dc.description.abstract | Gomesin: 47.83 +/- 0.48%), and Mac-1(+)F4/80(+) macrophages (Control: 11.76 +/- 3.4% | en |
dc.description.abstract | Gomesin: 27.13 +/- 4.0%). Additionally, macrophage increase was accompanied by an increase of macrophage phagocytosis (Control 20.85 +/- 1.53 | en |
dc.description.abstract | Gomesin 31.32 +/- 1 Geometric mean), interleukin 6 (Control: 47.24 +/- 1.9 ng/mL | en |
dc.description.abstract | Gomesin: 138.68 +/- 33.68 ng/mL) and monocyte chemoattractant protein-1 (Control: 0.872 +/- 0.093 ng/mL | en |
dc.description.abstract | Gomesin: 1.83 +/- 0.067 ng/mL). Thus, this report showed immunomodulatory activity of gomesin in the immune system of mice. (C) 2016 Elsevier Inc. All rights reserved. | en |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Bioquim, R Tres Maio 100, BR-04044020 Sao Paulo, SP, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Biofis, R Tres Maio 100, BR-04044020 Sao Paulo, SP, Brazil | |
dc.description.affiliation | Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquirm, Av Dr Candido Xavier Almeida Souza 200, Mogi Das Cruzes, SP, Brazil | |
dc.description.affiliationUnifesp | Departamento de Bioquímica, Universidade Federal de São Paulo, R. Três de Maio 100, 04044-020, São Paulo, SP, Brazil | |
dc.description.affiliationUnifesp | Departamento de Biofísica, Universidade Federal de São Paulo, R. Três de Maio 100, 04044-020, São Paulo, SP, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | INFAR/UNIFESP Confocal and Flow Cytometry Facility | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorshipID | FAPESP: 2013/09068-7 | |
dc.description.sponsorshipID | FAPESP: 2011/17584-0 | |
dc.description.sponsorshipID | CNPq: 473797/2013-5 | |
dc.description.sponsorshipID | FAPESP: 2012/20989-4 | |
dc.description.sponsorshipID | FAPESP: 2015/22901-5 | |
dc.format.extent | 41-45 | |
dc.identifier | http://dx.doi.org/10.1016/j.peptides.2016.09.003 | |
dc.identifier.citation | Peptides. New York, v. 85, p. 41-45, 2016. | |
dc.identifier.doi | 10.1016/j.peptides.2016.09.003 | |
dc.identifier.issn | 0196-9781 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/56854 | |
dc.identifier.wos | WOS:000387299200004 | |
dc.language.iso | eng | |
dc.publisher | Elsevier Science Inc | |
dc.relation.ispartof | Peptides | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Antimicrobial peptide | en |
dc.subject | Gomesin | en |
dc.subject | Immunomodulatory activity | en |
dc.subject | Macrophage activation | en |
dc.title | Gomesin acts in the immune system and promotes myeloid differentiation and monocyte/macrophage activation in mouse | en |
dc.type | info:eu-repo/semantics/article |